Results 151 to 160 of about 21,736,361 (314)

Minutes: Senate Committee on Information Technologies: September 10, 2013

, 2013
University of Minnesota: Senate Committee on Information Technologies. (2013). Minutes: Senate Committee on Information Technologies: September 10, 2013.
University of Minnesota: Senate Committee on Information Technologies
core  

Sub-optimal knowledge with positive attitude and belief of frontline health workers toward the use of information technologies: A mixed-method study from rural Haryana, India. [PDF]

J Educ Health Promot, 2022
Sathiyamoorthy R, Chandra A, Poudel S, Kumar R, Kumar R, Salve HR, Yadav K, Kant S, Ballabgarh Teaching and Research Group.   +8 more
europepmc   +1 more source

Profiling neoadjuvant therapy response in rectal cancer using meta‐analysis of publicly available transcriptomic RNA‐seq datasets

Molecular Oncology, EarlyView.
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic, Rafael Stroggilos, Mladen Marinkovic, Ana Djuric, Suzana Stojanovic‐Rundic, Radmila Jankovic, Sergi Castellvi‐Bel, Remond J.A. Fijneman, Antonia Vlahou, Jerome Zoidakis, Milena Cavic   +10 more
wiley   +1 more source

Minutes: Senate Committee on Information Technologies: April 7, 2015

, 2015
University of Minnesota: Senate Committee on Information Technologies. (2015). Minutes: Senate Committee on Information Technologies: April 7, 2015.
University of Minnesota: Senate Committee on Information Technologies
core  

Accessibility, Inclusion, and Rehabilitation Using Information Technologies. [PDF]

J Healthc Eng, 2020
Jaume-I-Capó A, González-Cid Y, Brooks AL, Cunningham S.   +3 more
europepmc   +1 more source

Gut microbiota alterations in patients with non‐small‐cell lung cancer undergoing chemoradiotherapy

Molecular Oncology, EarlyView.
We investigated the impact of concurrent chemoradiotherapy (CRT) on the gut microbiota in patients with locally advanced non‐small‐cell lung cancer. Overall gut microbiota composition remained largely stable throughout CRT while antibiotic exposure may influence microbial diversity.
Hanne Marte Nymoen, Zhi Zhao, Henrik Horndalsveen, Maria Moksnes Bjaanæs, Bjørn Henning Grønberg, Tarje Halvorsen, Tesfaye Madebo, Marianne Aanerud, Jussi Koivunen, Kersti Oselin, Saulius Cicenas, Nina Helbekkmo, Jarkko Ahvonen, Maria Silvoniemi, Tine Norman Alver, Tonje Dalen, Åsa Kristina Öjlert, Saima Jamil Farooqi, Åslaug Helland, Vilde Drageset Haakensen   +19 more
wiley   +1 more source

Minutes: Senate Committee on Information Technologies: November 4, 2014

, 2014
University of Minnesota: Senate Committee on Information Technologies. (2014). Minutes: Senate Committee on Information Technologies: November 4, 2014.
University of Minnesota: Senate Committee on Information Technologies
core  

Extracellular vesicle lipidomics liquid biopsy reveals systemic and tumor microenvironment metabolic reprogramming in ovarian cancer

Molecular Oncology, EarlyView.
Extracellular vesicle (EV) lipidomic profiling of plasma and ascites from patients with high‐grade serous ovarian cancer and of ovarian cancer cell lines reveals enrichment of triglycerides (TGs), diacylglycerols (DGs), phosphatidylcholine (PCs), sphingomyelins (SMs), reflecting tumor metabolic reprogramming.
Shikha Rani, Dominic Guanzon, Andrew Lai, Katherin Scholz‐Romero, Sarah Reed, Edita Ritmejeryte, Rohan Lourie, Naven Chetty, Kaltin Ferguson, Carlos Salomon   +9 more
wiley   +1 more source

Minutes: Senate Committee on Information Technologies: November 14, 2017

, 2017
University of Minnesota: Senate Committee on Information Technologies. (2017). Minutes: Senate Committee on Information Technologies: November 14, 2017.
University of Minnesota: Senate Committee on Information Technologies
core  

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

Molecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira, Ana Teixeira‐Marques, Rui Freitas, João A Carvalho, Sara Monteiro‐Reis, Giorgio I. Russo, Rui Henrique, Carmen Jerónimo   +7 more
wiley   +1 more source